Registry for Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome treatments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect real-world safety and performance data on AtriCure devices used for ablating cardiac tissue in patients with Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). It includes both retrospective and prospective data collection from multiple centers across the US and internationally. Patients who are scheduled for or have undergone treatment with AtriCure devices will be monitored to assess outcomes and safety profiles.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements

Exclusion Criteria:

1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
2. Subject with exclusion criteria required by FDA or local governance

Where it's running

• Loma Linda University Health
  Loma Linda, California, United States Recruiting
• Stanford University
  Palo Alto, California, United States Recruiting
• Sequoia Hospital
  Redwood City, California, United States Recruiting
• University of Florida
  Gainesville, Florida, United States Recruiting
• HCA Osceola Regional Medical Center
  Kissimmee, Florida, United States Recruiting
• Sarasota Memorial Hospital
  Sarasota, Florida, United States Recruiting

Study contacts

• Study coordinator: Registry Specialist
• Email: IST-Registry@atricure.com
• Phone: 866-349-2342

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Stellate ganglion block to help POTS symptoms

  This study tests whether a stellate ganglion block can improve symptoms and heart rate in adults with Postural Tachycardia Syndrome compared with a sham injection.

  Recruiting at 2 sites Stanford University · Stanford, California and 1 other locations · NCT06953661

• Understanding how the brain communicates in young people with Postural Tachycardia Syndrome

  This study is testing how young people with Postural Tachycardia Syndrome understand visual information to see how their brain communicates differently compared to healthy peers.

  Recruiting Virginia Commonwealth University · Richmond, Virginia · NCT05618054

• Observing autonomic neuropathies and Ehlers Danlos syndromes over time

  This study is trying to understand how autonomic neuropathies and Ehlers Danlos syndromes change over time in patients compared to healthy individuals.

  Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT04310644

• Effects of CO2 on heart rate and symptoms in POTS patients

  This study tests if breathing in higher levels of carbon dioxide can help improve heart rate and symptoms for people with Postural Orthostatic Tachycardia Syndrome (POTS).

  Recruiting University of Calgary · Calgary, Alberta · NCT04271878

• Comparing Propranolol and Ivabradine for treating POTS

  This study tests which medication, Propranolol or Ivabradine, works better to help people with Postural Tachycardia Syndrome feel better and manage their symptoms.

  Recruiting Phase 2 University of Calgary · Calgary, Alberta · NCT04186286

• Investigating antibodies in patients with Postural Tachycardia Syndrome

  This study is testing if people with Postural Tachycardia Syndrome have more specific antibodies in their blood compared to healthy individuals, which could help us understand the condition better.

  Recruiting University of Calgary · Calgary, Alberta · NCT02673996

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.